Lack of Impact of Hepatitis C Virus Coinfection in End-Stage Renal Disease Patients With Hepatitis B Virus Infection
Hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection results in more severe forms of liver disease in nonuremic patients; however, the impact of HCV coinfection is not clearly known in end-stage renal disease (ESRD) patients with HBV infection. We sought to determine the impact of HCV coi...
Gespeichert in:
| Veröffentlicht in: | Transplantation proceedings 2005-06, Vol.37 (5), p.2080-2082 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2082 |
|---|---|
| container_issue | 5 |
| container_start_page | 2080 |
| container_title | Transplantation proceedings |
| container_volume | 37 |
| creator | Moutinho, R.S. Perez, R.M. Pace, F.H.L. Ferreira, A.S.P. Cendoroglo, M. Medina-Pestana, J.O. Lanzoni, V.P. Silva, A.E.B. Ferraz, M.L.G. |
| description | Hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection results in more severe forms of liver disease in nonuremic patients; however, the impact of HCV coinfection is not clearly known in end-stage renal disease (ESRD) patients with HBV infection. We sought to determine the impact of HCV coinfection in HBV-infected ESRD patients.
The HBsAg-positive ESRD patients evaluated between March 1999 and May 2003 were divided into two groups: group B, HBV infection alone, and group BC, HBV-HCV coinfection (anti-HCV-positive). Both groups were compared regarding epidemiological, laboratory, and histological findings. A liver biopsy was obtained in cases with evidence of viral replication and/or elevated alanine aminotransferase.
One hundred patients (73% men) with mean age of 42 ± 11 years (55 patients in group B and 45 in group BC) were studied. Comparison between groups showed a difference in time on hemodialysis and duration of infection, which were higher in group BC (
P < .001 and
P = .001, respectively) and in history of blood transfusion, which was also more frequent in group BC (
P = .04). Liver biopsies, obtained from 15 patients in group B and 28 patients in group BC, showed no difference in frequency of septal fibrosis (60% in group B vs 48% in group BC,
P = .46) or interface hepatitis (73% vs 71%,
P = .99).
HBV-HCV coinfection was related to a longer time on hemodialysis, longer duration of infection, and history of blood transfusion. Contrary to nonuremic patients, HCV coinfection was not associated with more severe forms of liver disease in ESRD patients. |
| doi_str_mv | 10.1016/j.transproceed.2005.03.002 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67950272</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S004113450500237X</els_id><sourcerecordid>67950272</sourcerecordid><originalsourceid>FETCH-LOGICAL-c378t-87e51db892ddcc655de9b533b8b1fcdb996cee3afd8a563b0d78ee2d1899b97f3</originalsourceid><addsrcrecordid>eNqNkElPwzAQhS0EgrL8BWRx4JbgJU5iblC2SpVArEfLsSfg0ibFdpH497hqQRw5zYzmvTeaD6EjSnJKaHkyyaPXXZj73gDYnBEicsJzQtgGGtC64hkrGd9EA0IKmlFeiB20G8KEpJkVfBvtUCHLghfFAMWxNu-4b_FoNtcmLrsbmOvoogt4iJ-dX6Tau64FE13fYdfhy85mD1G_Ar6HTk_xhQugA-C7ZIMuBvzi4tufmPN1zOgnZB9ttXoa4GBd99DT1eXj8CYb316PhmfjzPCqjlldgaC2qSWz1phSCAuyEZw3dUNbYxspywSA69bWWpS8IbaqAZiltZSNrFq-h45XuQnVxwJCVDMXDEynuoN-EVRZSUFYxZLwdCU0vg_BQ6vm3s20_1KUqCVzNVF_maslc0W4SsyT-XB9ZdHM0u7XuoacBBcrAaRfPx14FUwCZcA6n4Ao27v_3PkGFJ6bNg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67950272</pqid></control><display><type>article</type><title>Lack of Impact of Hepatitis C Virus Coinfection in End-Stage Renal Disease Patients With Hepatitis B Virus Infection</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Moutinho, R.S. ; Perez, R.M. ; Pace, F.H.L. ; Ferreira, A.S.P. ; Cendoroglo, M. ; Medina-Pestana, J.O. ; Lanzoni, V.P. ; Silva, A.E.B. ; Ferraz, M.L.G.</creator><creatorcontrib>Moutinho, R.S. ; Perez, R.M. ; Pace, F.H.L. ; Ferreira, A.S.P. ; Cendoroglo, M. ; Medina-Pestana, J.O. ; Lanzoni, V.P. ; Silva, A.E.B. ; Ferraz, M.L.G.</creatorcontrib><description>Hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection results in more severe forms of liver disease in nonuremic patients; however, the impact of HCV coinfection is not clearly known in end-stage renal disease (ESRD) patients with HBV infection. We sought to determine the impact of HCV coinfection in HBV-infected ESRD patients.
The HBsAg-positive ESRD patients evaluated between March 1999 and May 2003 were divided into two groups: group B, HBV infection alone, and group BC, HBV-HCV coinfection (anti-HCV-positive). Both groups were compared regarding epidemiological, laboratory, and histological findings. A liver biopsy was obtained in cases with evidence of viral replication and/or elevated alanine aminotransferase.
One hundred patients (73% men) with mean age of 42 ± 11 years (55 patients in group B and 45 in group BC) were studied. Comparison between groups showed a difference in time on hemodialysis and duration of infection, which were higher in group BC (
P < .001 and
P = .001, respectively) and in history of blood transfusion, which was also more frequent in group BC (
P = .04). Liver biopsies, obtained from 15 patients in group B and 28 patients in group BC, showed no difference in frequency of septal fibrosis (60% in group B vs 48% in group BC,
P = .46) or interface hepatitis (73% vs 71%,
P = .99).
HBV-HCV coinfection was related to a longer time on hemodialysis, longer duration of infection, and history of blood transfusion. Contrary to nonuremic patients, HCV coinfection was not associated with more severe forms of liver disease in ESRD patients.</description><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/j.transproceed.2005.03.002</identifier><identifier>PMID: 15964344</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Female ; Hepacivirus - isolation & purification ; Hepatitis B e Antigens - blood ; Hepatitis B Surface Antigens - analysis ; Hepatitis C - complications ; Humans ; Kidney Failure, Chronic - surgery ; Kidney Failure, Chronic - virology ; Kidney Transplantation ; Male ; Renal Dialysis ; Treatment Outcome ; Uremia - surgery</subject><ispartof>Transplantation proceedings, 2005-06, Vol.37 (5), p.2080-2082</ispartof><rights>2005 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c378t-87e51db892ddcc655de9b533b8b1fcdb996cee3afd8a563b0d78ee2d1899b97f3</citedby><cites>FETCH-LOGICAL-c378t-87e51db892ddcc655de9b533b8b1fcdb996cee3afd8a563b0d78ee2d1899b97f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S004113450500237X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15964344$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moutinho, R.S.</creatorcontrib><creatorcontrib>Perez, R.M.</creatorcontrib><creatorcontrib>Pace, F.H.L.</creatorcontrib><creatorcontrib>Ferreira, A.S.P.</creatorcontrib><creatorcontrib>Cendoroglo, M.</creatorcontrib><creatorcontrib>Medina-Pestana, J.O.</creatorcontrib><creatorcontrib>Lanzoni, V.P.</creatorcontrib><creatorcontrib>Silva, A.E.B.</creatorcontrib><creatorcontrib>Ferraz, M.L.G.</creatorcontrib><title>Lack of Impact of Hepatitis C Virus Coinfection in End-Stage Renal Disease Patients With Hepatitis B Virus Infection</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><description>Hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection results in more severe forms of liver disease in nonuremic patients; however, the impact of HCV coinfection is not clearly known in end-stage renal disease (ESRD) patients with HBV infection. We sought to determine the impact of HCV coinfection in HBV-infected ESRD patients.
The HBsAg-positive ESRD patients evaluated between March 1999 and May 2003 were divided into two groups: group B, HBV infection alone, and group BC, HBV-HCV coinfection (anti-HCV-positive). Both groups were compared regarding epidemiological, laboratory, and histological findings. A liver biopsy was obtained in cases with evidence of viral replication and/or elevated alanine aminotransferase.
One hundred patients (73% men) with mean age of 42 ± 11 years (55 patients in group B and 45 in group BC) were studied. Comparison between groups showed a difference in time on hemodialysis and duration of infection, which were higher in group BC (
P < .001 and
P = .001, respectively) and in history of blood transfusion, which was also more frequent in group BC (
P = .04). Liver biopsies, obtained from 15 patients in group B and 28 patients in group BC, showed no difference in frequency of septal fibrosis (60% in group B vs 48% in group BC,
P = .46) or interface hepatitis (73% vs 71%,
P = .99).
HBV-HCV coinfection was related to a longer time on hemodialysis, longer duration of infection, and history of blood transfusion. Contrary to nonuremic patients, HCV coinfection was not associated with more severe forms of liver disease in ESRD patients.</description><subject>Adult</subject><subject>Female</subject><subject>Hepacivirus - isolation & purification</subject><subject>Hepatitis B e Antigens - blood</subject><subject>Hepatitis B Surface Antigens - analysis</subject><subject>Hepatitis C - complications</subject><subject>Humans</subject><subject>Kidney Failure, Chronic - surgery</subject><subject>Kidney Failure, Chronic - virology</subject><subject>Kidney Transplantation</subject><subject>Male</subject><subject>Renal Dialysis</subject><subject>Treatment Outcome</subject><subject>Uremia - surgery</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkElPwzAQhS0EgrL8BWRx4JbgJU5iblC2SpVArEfLsSfg0ibFdpH497hqQRw5zYzmvTeaD6EjSnJKaHkyyaPXXZj73gDYnBEicsJzQtgGGtC64hkrGd9EA0IKmlFeiB20G8KEpJkVfBvtUCHLghfFAMWxNu-4b_FoNtcmLrsbmOvoogt4iJ-dX6Tau64FE13fYdfhy85mD1G_Ar6HTk_xhQugA-C7ZIMuBvzi4tufmPN1zOgnZB9ttXoa4GBd99DT1eXj8CYb316PhmfjzPCqjlldgaC2qSWz1phSCAuyEZw3dUNbYxspywSA69bWWpS8IbaqAZiltZSNrFq-h45XuQnVxwJCVDMXDEynuoN-EVRZSUFYxZLwdCU0vg_BQ6vm3s20_1KUqCVzNVF_maslc0W4SsyT-XB9ZdHM0u7XuoacBBcrAaRfPx14FUwCZcA6n4Ao27v_3PkGFJ6bNg</recordid><startdate>20050601</startdate><enddate>20050601</enddate><creator>Moutinho, R.S.</creator><creator>Perez, R.M.</creator><creator>Pace, F.H.L.</creator><creator>Ferreira, A.S.P.</creator><creator>Cendoroglo, M.</creator><creator>Medina-Pestana, J.O.</creator><creator>Lanzoni, V.P.</creator><creator>Silva, A.E.B.</creator><creator>Ferraz, M.L.G.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050601</creationdate><title>Lack of Impact of Hepatitis C Virus Coinfection in End-Stage Renal Disease Patients With Hepatitis B Virus Infection</title><author>Moutinho, R.S. ; Perez, R.M. ; Pace, F.H.L. ; Ferreira, A.S.P. ; Cendoroglo, M. ; Medina-Pestana, J.O. ; Lanzoni, V.P. ; Silva, A.E.B. ; Ferraz, M.L.G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c378t-87e51db892ddcc655de9b533b8b1fcdb996cee3afd8a563b0d78ee2d1899b97f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Female</topic><topic>Hepacivirus - isolation & purification</topic><topic>Hepatitis B e Antigens - blood</topic><topic>Hepatitis B Surface Antigens - analysis</topic><topic>Hepatitis C - complications</topic><topic>Humans</topic><topic>Kidney Failure, Chronic - surgery</topic><topic>Kidney Failure, Chronic - virology</topic><topic>Kidney Transplantation</topic><topic>Male</topic><topic>Renal Dialysis</topic><topic>Treatment Outcome</topic><topic>Uremia - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moutinho, R.S.</creatorcontrib><creatorcontrib>Perez, R.M.</creatorcontrib><creatorcontrib>Pace, F.H.L.</creatorcontrib><creatorcontrib>Ferreira, A.S.P.</creatorcontrib><creatorcontrib>Cendoroglo, M.</creatorcontrib><creatorcontrib>Medina-Pestana, J.O.</creatorcontrib><creatorcontrib>Lanzoni, V.P.</creatorcontrib><creatorcontrib>Silva, A.E.B.</creatorcontrib><creatorcontrib>Ferraz, M.L.G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moutinho, R.S.</au><au>Perez, R.M.</au><au>Pace, F.H.L.</au><au>Ferreira, A.S.P.</au><au>Cendoroglo, M.</au><au>Medina-Pestana, J.O.</au><au>Lanzoni, V.P.</au><au>Silva, A.E.B.</au><au>Ferraz, M.L.G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lack of Impact of Hepatitis C Virus Coinfection in End-Stage Renal Disease Patients With Hepatitis B Virus Infection</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2005-06-01</date><risdate>2005</risdate><volume>37</volume><issue>5</issue><spage>2080</spage><epage>2082</epage><pages>2080-2082</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><abstract>Hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection results in more severe forms of liver disease in nonuremic patients; however, the impact of HCV coinfection is not clearly known in end-stage renal disease (ESRD) patients with HBV infection. We sought to determine the impact of HCV coinfection in HBV-infected ESRD patients.
The HBsAg-positive ESRD patients evaluated between March 1999 and May 2003 were divided into two groups: group B, HBV infection alone, and group BC, HBV-HCV coinfection (anti-HCV-positive). Both groups were compared regarding epidemiological, laboratory, and histological findings. A liver biopsy was obtained in cases with evidence of viral replication and/or elevated alanine aminotransferase.
One hundred patients (73% men) with mean age of 42 ± 11 years (55 patients in group B and 45 in group BC) were studied. Comparison between groups showed a difference in time on hemodialysis and duration of infection, which were higher in group BC (
P < .001 and
P = .001, respectively) and in history of blood transfusion, which was also more frequent in group BC (
P = .04). Liver biopsies, obtained from 15 patients in group B and 28 patients in group BC, showed no difference in frequency of septal fibrosis (60% in group B vs 48% in group BC,
P = .46) or interface hepatitis (73% vs 71%,
P = .99).
HBV-HCV coinfection was related to a longer time on hemodialysis, longer duration of infection, and history of blood transfusion. Contrary to nonuremic patients, HCV coinfection was not associated with more severe forms of liver disease in ESRD patients.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15964344</pmid><doi>10.1016/j.transproceed.2005.03.002</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0041-1345 |
| ispartof | Transplantation proceedings, 2005-06, Vol.37 (5), p.2080-2082 |
| issn | 0041-1345 1873-2623 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67950272 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adult Female Hepacivirus - isolation & purification Hepatitis B e Antigens - blood Hepatitis B Surface Antigens - analysis Hepatitis C - complications Humans Kidney Failure, Chronic - surgery Kidney Failure, Chronic - virology Kidney Transplantation Male Renal Dialysis Treatment Outcome Uremia - surgery |
| title | Lack of Impact of Hepatitis C Virus Coinfection in End-Stage Renal Disease Patients With Hepatitis B Virus Infection |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T02%3A08%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lack%20of%20Impact%20of%20Hepatitis%20C%20Virus%20Coinfection%20in%20End-Stage%20Renal%20Disease%20Patients%20With%20Hepatitis%20B%20Virus%20Infection&rft.jtitle=Transplantation%20proceedings&rft.au=Moutinho,%20R.S.&rft.date=2005-06-01&rft.volume=37&rft.issue=5&rft.spage=2080&rft.epage=2082&rft.pages=2080-2082&rft.issn=0041-1345&rft.eissn=1873-2623&rft_id=info:doi/10.1016/j.transproceed.2005.03.002&rft_dat=%3Cproquest_cross%3E67950272%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67950272&rft_id=info:pmid/15964344&rft_els_id=S004113450500237X&rfr_iscdi=true |